<DOC>
	<DOCNO>NCT00841672</DOCNO>
	<brief_summary>This study compare blood pressure ( BP ) lower effect combination aliskiren/amlodipine 300/10 mg versus amlodipine 10 mg monotherapy patient moderate severe hypertension test hypothesis combination aliskiren/amlodipine produce superior reduction baseline mean sit systolic blood pressure ( msSBP ) 8 week treatment .</brief_summary>
	<brief_title>Efficacy Safety Combination Aliskiren ( 300 mg ) Amlodipine ( 10 mg ) Compared Amlodipine ( 10 mg ) Monotherapy Patients With Moderate Severe Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Outpatients ≥ 18 year age Patients diagnosis moderate severe hypertension , define msSBP ≥ 160 mmHg &lt; 200 mmHg Visit 2 Mild moderate hypertension Pregnant nursing ( lactate ) woman Women childbearing potential Previous current diagnosis heart failure New York Heart Association ( NYHA ) Class IIIV . Serum potassium ≥ 5.3 mEq/L ( mmol/L ) Visit 1 . Uncontrolled Type 1 Type 2 diabetes mellitus Hypersensitivity renin inhibitor , calcium channel blocker , drug Similar chemical structure History hypertensive encephalopathy cerebrovascular accident , history transient ischemic attack ( TIA ) , myocardial infarction , coronary bypass surgery , percutaneous coronary intervention Patients combination 3 antihypertensive medication Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>systolic blood pressure</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>aliskiren</keyword>
	<keyword>amlodipine</keyword>
</DOC>